The FDA’s Center for Drug Evaluation and Research (CDER) recently unveiled the launch of the CDER Center for Clinical Trial Innovation (C3TI), which aims to drive clinical trial innovation. When asked to assess the potential impact of the center, Charles Fisher, founder and CEO of Unlearn, said: “The truth is, I don’t know. I’m sort…
Pharmaceutical firms betting big on AI struggle to find the right people
![[Adobe FIrefly]](https://www.drugdiscoverytrends.com/wp-content/uploads/2024/04/Firefly-Visualize-a-photo-realistic-HD-pharmaceutical-laboratory-image-with-concentrated-workers-in_-e1712103436381-268x170.png)
Three-quarters of IT decision-makers at pharmaceutical companies plan to invest from $500,000 to $5 million in AI this year which, for many, doubles their budgets over the past year. That’s one of the findings based on the cross-industry research report involving 1,400 IT decision makers from Rackspace and AWS. “In terms of AI adoption, almost…